Clinical Trial

Pulsed Radiofrequency Versus Hyaluronidase Hydrodissection for Treatment of Carpal Tunnel Syndrome

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 9, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to compare the clinical efficacy and safety of ultrasound-guided pulsed radiofrequency and hyaluronidase hydrodissection in the treatment of carpal tunnel syndrome. This research seeks to evaluate both techniques in terms of pain relief, functional improvement, nerve conduction parameters, and potential complications, in order to identify the more effective minimally invasive approach for managing carpal tunnel syndrome.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-25.
Trial Details
NCT Number NCT07269613
Lead Sponsor Sohag University
Conditions Carpal Tunnel Syndrome (CTS)
Enrollment 56 participants
Start Date 2025-12
Primary Completion 2026-01 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2025-12-09